ATE284705T1 - Behandlung von allergischer rhinitis mit bestimmten vasoaktiven aminbindenden proteinen - Google Patents

Behandlung von allergischer rhinitis mit bestimmten vasoaktiven aminbindenden proteinen

Info

Publication number
ATE284705T1
ATE284705T1 AT00954788T AT00954788T ATE284705T1 AT E284705 T1 ATE284705 T1 AT E284705T1 AT 00954788 T AT00954788 T AT 00954788T AT 00954788 T AT00954788 T AT 00954788T AT E284705 T1 ATE284705 T1 AT E284705T1
Authority
AT
Austria
Prior art keywords
treatment
allergic rhinitis
binding proteins
vasoactive amine
certain vasoactive
Prior art date
Application number
AT00954788T
Other languages
English (en)
Inventor
Patricia Anne Nuttall
Guido Christiaan Paesen
Original Assignee
Evolutec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolutec Ltd filed Critical Evolutec Ltd
Application granted granted Critical
Publication of ATE284705T1 publication Critical patent/ATE284705T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00954788T 1999-09-01 2000-08-24 Behandlung von allergischer rhinitis mit bestimmten vasoaktiven aminbindenden proteinen ATE284705T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920673.2A GB9920673D0 (en) 1999-09-01 1999-09-01 Treatment of allergic rhinitis
PCT/GB2000/003287 WO2001016164A2 (en) 1999-09-01 2000-08-24 Treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
ATE284705T1 true ATE284705T1 (de) 2005-01-15

Family

ID=10860169

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954788T ATE284705T1 (de) 1999-09-01 2000-08-24 Behandlung von allergischer rhinitis mit bestimmten vasoaktiven aminbindenden proteinen

Country Status (15)

Country Link
US (1) US6794360B2 (de)
EP (1) EP1207899B1 (de)
JP (1) JP2003508410A (de)
CN (1) CN1372471A (de)
AT (1) ATE284705T1 (de)
AU (1) AU778514B2 (de)
BR (1) BR0013655A (de)
CA (1) CA2382570A1 (de)
DE (1) DE60016762T2 (de)
ES (1) ES2233423T3 (de)
GB (1) GB9920673D0 (de)
MX (1) MXPA02002044A (de)
NZ (1) NZ517765A (de)
PT (1) PT1207899E (de)
WO (1) WO2001016164A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307544D0 (en) * 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
GB0809279D0 (en) * 2008-05-21 2008-06-25 Varleigh Ltd Histamine binding protein
GB201720505D0 (en) * 2017-12-08 2018-01-24 Volution Immuno Pharmaceuticals Sa Methods for treatment of neuropathic pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2283239A (en) * 1993-10-29 1995-05-03 Ucb Sa Human H1 histamine receptor
NZ332648A (en) * 1996-05-18 2000-05-26 Oxford Vacs Ltd Vasoactive amine binding proteins (VABP) and vasoactive amine binding molecules (VABM)
AU763299B2 (en) * 1997-11-26 2003-07-17 Evolutec Limited Histamine and serotonin binding molecules

Also Published As

Publication number Publication date
EP1207899B1 (de) 2004-12-15
DE60016762D1 (de) 2005-01-20
US20020193306A1 (en) 2002-12-19
DE60016762T2 (de) 2005-12-08
BR0013655A (pt) 2002-05-07
EP1207899A2 (de) 2002-05-29
WO2001016164A2 (en) 2001-03-08
PT1207899E (pt) 2005-03-31
WO2001016164A3 (en) 2001-05-03
AU6714300A (en) 2001-03-26
NZ517765A (en) 2004-11-26
CN1372471A (zh) 2002-10-02
AU778514B2 (en) 2004-12-09
GB9920673D0 (en) 1999-11-03
MXPA02002044A (es) 2003-08-20
HK1043541A1 (en) 2002-09-20
CA2382570A1 (en) 2001-03-08
US6794360B2 (en) 2004-09-21
JP2003508410A (ja) 2003-03-04
ES2233423T3 (es) 2005-06-16

Similar Documents

Publication Publication Date Title
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ATE306481T1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE60016762D1 (de) Behandlung von allergischer rhinitis mit bestimmten vasoaktiven aminbindenden proteinen
DE60125212D1 (de) Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen.
ATE289203T1 (de) Behandlung von konjunktivitis mit histacalin proteinen
ATE338566T1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
ATE281165T1 (de) Verwendung von pramipexol zur behandlung von restless-legs-syndrom
DE602004009414D1 (de) BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN MIT N-2,3,3-TETRAMETHYLBICYCLOi2.2.1öHEPTAN-2-AMINE
DE50110552D1 (de) Verfahren zur behandlung von instabiler angina pectoris
ATE246924T1 (de) Neue therapeutische verwendung von nicergoline
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
DE60017136D1 (de) Behandlung von angiogenese-abhängigen erkrankungen mit dextrinsulphat
DE60107516D1 (de) Verwendung von Pregabalin zur Asthma Behandlung
LU91009B1 (de) Behandlung von Verbrennungen
ATE331524T1 (de) Verwendung von lps zur behandlung intestinaler entzündungsprozesse
DE60213230D1 (de) Verwendung von NF-Kappa.B Inhibitoren zur Behandlung von Augentrockenheit
ATE459372T1 (de) Vorbeugung und behandlung von p. gingivalis infektion
DE60002143D1 (de) Behandlung autoimmunerkrankungen in säugern
DE10085032T1 (de) Behandlung von Nebenwirkungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1207899

Country of ref document: EP

REN Ceased due to non-payment of the annual fee